科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02487 科笛-B

圣诞节后第一个工作日休市 12-24 12:08:29

6.690

-0.130

-1.91%

最高6.930	最低6.600	成交量57.34万
今开6.930	昨收6.820	日振幅4.84%
总市值21.34亿	流通市值21.34亿	总股本3.19亿
成交额384.59万	换手率0.18%	流通股本3.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"科笛-B","latestPrice":6.69,"timestamp":1735013309015,"preClose":6.82,"halted":0,"volume":573400,"delay":0,"floatShares":319000000,"shares":319000000,"eps":-10.24616,"marketStatus":"圣诞节后第一个工作日休市","marketStatusCode":7,"change":-0.13,"latestTime":"12-24 12:08:29","open":6.93,"high":6.93,"low":6.6,"amount":3845924,"amplitude":0.048387,"askPrice":6.69,"askSize":2600,"bidPrice":6.62,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":-1.8341741194524346,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735263000000},"adr":0,"listingDate":1686499200000,"adjPreClose":6.82,"openAndCloseTimeList":[[1735003800000,1735012800000]],"volumeRatio":1.5133643648564383,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02487/wiki","defaultTab":"wiki","newsList":[{"id":"2490592879","title":"科笛-B12月12日遭主力抛售235万元 环比增加370.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490592879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490592879?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:15","pubTimestamp":1733991346,"startTime":"0","endTime":"0","summary":"12月12日, 科笛-B股价跌0.28%，报收7.23元，成交金额2009万元，换手率0.88%，振幅5.10%，量比2.47。科笛-B今日主力资金净流出235万元，上一交易日主力净流出50万元，今日环比增加370.00%。该股近5个交易日下跌5.50%，主力资金累计净流出539万元；近20日主力资金累计净流出852万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161615a1e88506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161615a1e88506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2490588064","title":"科笛-B12月11日主力资金流出50万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490588064","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490588064?lang=zh_cn&edition=full","pubTime":"2024-12-11 16:17","pubTimestamp":1733905031,"startTime":"0","endTime":"0","summary":"12月11日, 科笛-B股价跌0.96%，报收7.25元，成交金额575万元，换手率0.25%，振幅3.28%，量比0.68。科笛-B今日主力资金净流出50万元，连续7日净流出，上一交易日主力净流出105万元，今日环比减少52.38%。该股近5个交易日下跌4.23%，主力资金累计净流出323万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出640万元，其中净流出天数为12日。该股主力净额占比0.02%，港股市场排名2514/2650。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161734ab6efb37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161734ab6efb37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2490052128","title":"科笛-B盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490052128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490052128?lang=zh_cn&edition=full","pubTime":"2024-12-10 14:03","pubTimestamp":1733810593,"startTime":"0","endTime":"0","summary":"2024年12月10日下午盘14时03分，科笛-B股票出现异动，股价急速跳水5.11%。截至发稿，该股报7.060港元/股，成交量80.38万股，换手率0.25%，振幅5.24%。科笛-B股票所在的生物技术行业中，整体跌幅为1.52%。科笛-B公司简介：科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210140313ab6bea7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210140313ab6bea7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2490710224","title":"科笛-B12月09日主力资金流出99万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490710224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490710224?lang=zh_cn&edition=full","pubTime":"2024-12-09 16:15","pubTimestamp":1733732137,"startTime":"0","endTime":"0","summary":"12月09日, 科笛-B股价跌1.98%，报收7.44元，成交金额1078万元，换手率0.47%，振幅7.91%，量比1.54。科笛-B今日主力资金净流出99万元，连续5日净流出，上一交易日主力净流出51万元，今日环比增加94.12%。该股近5个交易日下跌3.85%，主力资金累计净流出324万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出420万元，其中净流出天数为10日。该股主力净额占比0.04%，港股市场排名2571/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161551ab69419e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209161551ab69419e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2490320713","title":"科笛-B(02487)下跌5.01%，报7.21元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490320713","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490320713?lang=zh_cn&edition=full","pubTime":"2024-12-09 13:55","pubTimestamp":1733723746,"startTime":"0","endTime":"0","summary":"12月9日，科笛-B(02487)盘中下跌5.01%，截至13:55，报7.21元/股，成交549.7万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/09135546159483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2490371367","title":"科笛-B盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490371367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490371367?lang=zh_cn&edition=full","pubTime":"2024-12-09 13:55","pubTimestamp":1733723741,"startTime":"0","endTime":"0","summary":"2024年12月09日下午盘13时55分，科笛-B股票出现波动，股价大幅下跌5.01%。截至发稿，该股报7.210港元/股，成交量74.9万股，换手率0.24%，振幅5.93%。科笛-B股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，永泰生物-B、嘉和生物-B、云康集团涨幅较大，振幅较大的相关个股有晶泰科技、华康生物医学、永泰生物-B，振幅分别为25.30%、19.26%、18.33%。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209135541a1df8c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209135541a1df8c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2489040146","title":"科笛-B12月06日遭主力抛售51万元 环比增加168.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489040146","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489040146?lang=zh_cn&edition=full","pubTime":"2024-12-06 16:16","pubTimestamp":1733472988,"startTime":"0","endTime":"0","summary":"12月06日, 科笛-B股价跌0.52%，报收7.59元，成交金额539万元，换手率0.22%，振幅2.88%，量比0.69。科笛-B今日主力资金净流出51万元，连续4日净流出，上一交易日主力净流出19万元，今日环比增加168.42%。该股近5个交易日下跌1.93%，主力资金累计净流出226万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出321万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161704a1d8a27c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161704a1d8a27c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2489439033","title":"科笛-B12月05日主力资金流出19万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2489439033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489439033?lang=zh_cn&edition=full","pubTime":"2024-12-05 16:15","pubTimestamp":1733386516,"startTime":"0","endTime":"0","summary":"12月05日, 科笛-B股价涨0.93%，报收7.63元，成交金额987万元，换手率0.41%，振幅2.78%，量比1.30。科笛-B今日主力资金净流出19万元，连续3日净流出，上一交易日主力净流出31万元，今日环比减少38.71%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为60.00%，平均跌幅为1.33%。该股近5个交易日下跌5.80%，主力资金累计净流出175万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出309万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205161532a1d5cdfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205161532a1d5cdfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2488189981","title":"科笛-B(02487)下跌5.1%，报7.44元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488189981","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488189981?lang=zh_cn&edition=full","pubTime":"2024-12-04 10:55","pubTimestamp":1733280917,"startTime":"0","endTime":"0","summary":"12月4日，科笛-B(02487)盘中下跌5.1%，截至10:55，报7.44元/股，成交221.1万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/04105545989354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2488900429","title":"科笛-B盘中异动 股价大跌5.61%报7.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488900429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488900429?lang=zh_cn&edition=full","pubTime":"2024-12-04 09:31","pubTimestamp":1733275904,"startTime":"0","endTime":"0","summary":"2024年12月04日早盘09时31分，科笛-B股票出现波动，股价快速下挫5.61%。截至发稿，该股报7.400港元/股，成交量11.06万股，换手率0.03%，振幅2.81%。资金方面，该股资金流入6.1594万港元，流出23.8396万港元。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科笛-B股票所在的生物技术行业中，整体跌幅为0.47%。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093144971b7a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204093144971b7a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2487582612","title":"科笛-B(02487)下跌5.8%，报7.63元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2487582612","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487582612?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:59","pubTimestamp":1732867159,"startTime":"0","endTime":"0","summary":"11月29日，科笛-B(02487)盘中下跌5.8%，截至15:59，报7.63元/股，成交745.48万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/29155945838791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2487823175","title":"科笛-B盘中异动 临近收盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487823175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487823175?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:58","pubTimestamp":1732867115,"startTime":"0","endTime":"0","summary":"2024年11月29日临近收盘15时58分，科笛-B股票出现异动，股价急速下跌5.19%。截至发稿，该股报7.680港元/股，成交量92.88万股，换手率0.29%，振幅7.65%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。科笛-B股票所在的生物技术行业中，整体涨幅为1.70%。科笛-B公司简介：科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112915583598e4595f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112915583598e4595f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2487376028","title":"科笛-B新药CU-20401 II期临床获显著疗效数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2487376028","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487376028?lang=zh_cn&edition=full","pubTime":"2024-11-29 09:09","pubTimestamp":1732842599,"startTime":"0","endTime":"0","summary":"科笛-B（02487）发布公告，宣布其潜在1类新药CU-20401（重组突变胶原酶）在中国开展的II期临床试验已获得顶线数据，且达到了主要研究终点，结果具有统计学显著性及临床意义。该临床试验为多中心、随机、双盲及安慰剂对照试验，共入组108例受试者，分析显示低剂量和高剂量CU-20401组的治疗有效率均高于安慰剂对照组，且有效率差异具有统计学意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411293254457439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2487373113","title":"科笛(02487.HK)新药CU-20401临床展现出显著且稳健疗效优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2487373113","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487373113?lang=zh_cn&edition=full","pubTime":"2024-11-29 08:38","pubTimestamp":1732840680,"startTime":"0","endTime":"0","summary":"科笛(02487.HK) 公布，其潜在1类新药CU-20401 (重组突变胶原酶)于中国开展的用于治疗颏下脂肪堆积的II期临床试验已获得顶线数据。数据显示，该临床试验达到主要研究终点，结果具有统计学显著性及临床意义。分析结果显示，于有效性方面，主要疗效终点数据显示，低剂量CU-20401组和高剂量CU20401组的治疗有效率均高于安慰剂对照组，且有效率差异均具有统计学意义。次要疗效终点数据也展现出类似的疗效优势。整体上，CU-20401展现出显著且稳健的疗效优势，安全性良好。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1400454/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2487249933","title":"科笛-B(02487)：CU-20401(重组突变胶塬酶)治疗颏下脂肪堆积II期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2487249933","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487249933?lang=zh_cn&edition=full","pubTime":"2024-11-29 06:58","pubTimestamp":1732834724,"startTime":"0","endTime":"0","summary":"数据显示，该临床试验达到主要研究终点，结果具有统计学显著性及临床意义。整体上，CU-20401展现出显著且稳健的疗效优势，安全性良好CU-20401是一种重组突变胶原酶，其靶向肥胖、超重或其他与局部脂肪堆积相关的代谢疾病。经局部注射后，CU-20401通过降解皮下脂肪层中的细胞外基质胶原蛋白，导致脂肪细胞凋亡，预计可有效减少局部脂肪堆积。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02487","03347","BK1161","BK1141","BK1583","BK1576"],"gpt_icon":0},{"id":"2487132443","title":"科笛-B：CU-20401(重组突变胶原酶)治疗颏下脂肪堆积II期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2487132443","media":"格隆汇资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487132443?lang=zh_cn&edition=full","pubTime":"2024-11-29 06:32","pubTimestamp":1732833131,"startTime":"0","endTime":"0","summary":"格隆汇11月29日丨科笛-B发布公告，集团的潜在1类新药CU-20401于中国开展的用于治疗颏下脂肪堆积的II期临床试验已获得顶线数据。分析结果显示：于有效性方面，主要疗效终点数据显示，低剂量CU-20401组和高剂量CU20401组的治疗有效率均高于安慰剂对照组，且有效率差异均具有统计学意义。整体上，CU-20401展现出显著且稳健的疗效优势，安全性良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129063215abe6d917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129063215abe6d917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","02487","03347","BK1161","BK1141","BK1583"],"gpt_icon":0},{"id":"2486353270","title":"科笛-B(02487)：CU-40102(外用非那雄胺喷雾剂)及CU-30101(局部外用利多卡因丁卡因乳膏剂)中国III期临床试验结果在第十九届CDA年会发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2486353270","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486353270?lang=zh_cn&edition=full","pubTime":"2024-11-28 12:12","pubTimestamp":1732767128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科笛-B 发布公告，该集团治疗雄激素性脱发产品CU-40102及用于皮肤表皮手术的CU-30101的中国III期临床试验结果在第十九届中国医师协会皮肤科医师年会暨全国美容皮肤科学大会以电子壁报形式发布。在安全性方面， CU-30101的整体安全性良好，无重度不良事件或严重不良事件发生。CU-30101的药品上市许可申请已于2024年7月获得国家药监局受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","BK1576","III","02487","03347","BK1141","BK1161","BK1583"],"gpt_icon":0},{"id":"2486355335","title":"科笛-B(02487.HK)公布两产品内地III期临床试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2486355335","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486355335?lang=zh_cn&edition=full","pubTime":"2024-11-28 12:01","pubTimestamp":1732766460,"startTime":"0","endTime":"0","summary":"科笛-B(02487.HK) 公布，其治疗雄激素性脱发产品CU-40102以及用于皮肤表皮手术的CU-30101的中国III期临床试验结果在全国美容皮肤科学大会(CDA年会)上公布。其中，CU-40102组的受试者的顶部秃发目标区域内的总毛发计数及终毛计数相比于基线改善均显著优于安慰剂组，达到主要终点指标和主要的次要终点指标，而且疗效从第12周起开始展现。至于CU-30101，其临床试验结果显示CU-30101与Pliaglis®镇痛疗效相当，达到主要终点。两款产品的药品上市许可申请已在今年获国家药监局受理。(vc/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230602115202398_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1400204/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1161","BK1576","03347","BK1141","02487"],"gpt_icon":0},{"id":"2486365983","title":"科笛-B盘中异动 早盘大幅上涨6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486365983","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486365983?lang=zh_cn&edition=full","pubTime":"2024-11-28 09:31","pubTimestamp":1732757460,"startTime":"0","endTime":"0","summary":"2024年11月28日早盘09时31分，科笛-B股票出现波动，股价急速拉升6.46%。截至发稿，该股报8.730港元/股，成交量13.26万股，换手率0.04%，振幅6.95%。科笛-B股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，科笛-B、再鼎医药、云顶新耀-B涨幅较大，振幅较大的相关个股有科笛-B、九源基因、再鼎医药，振幅分别为6.95%、5.39%、5.24%。该公司在中国国内市场和海外市场开展其业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112809310098e45086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112809310098e45086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2486620040","title":"科笛-B(02487)上涨5.14%，报8.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486620040","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486620040?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:53","pubTimestamp":1732607598,"startTime":"0","endTime":"0","summary":"11月26日，科笛-B(02487)盘中上涨5.14%，截至15:53，报8.8元/股，成交495.0万元。科笛集团是一家以研发为主导的生物制药公司，主要专注于皮肤病治疗及护理市场，提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台，形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势，并由经验丰富的管理团队负责运营。截至2024年中报，科笛-B营业总收入9557.5万元、净利润-2.01亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/26155345687391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科笛-B(02487)上涨5.14%，报8.8元/股","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02487","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cutiatx.com","stockEarnings":[{"period":"1week","weight":-0.0402},{"period":"1month","weight":-0.1978},{"period":"3month","weight":-0.5534},{"period":"6month","weight":0.079},{"period":"1year","weight":-0.3173},{"period":"ytd","weight":-0.3907}],"compareEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.0452},{"period":"3month","weight":0.0507},{"period":"6month","weight":0.1344},{"period":"1year","weight":0.23},{"period":"ytd","weight":0.179}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司致力于开发全面的解决方案，以满足患者及消费者在广泛皮肤病治疗及护理市场中多样化需求。该公司主要从事其核心产品CU-20401的临床试验。该产品主要用于治疗颏下脂肪堆积。该公司在中国国内市场和海外市场开展其业务。","exchange":"SEHK","name":"科笛-B","nameEN":"CUTIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科笛-B,02487,科笛-B股票,科笛-B股票老虎,科笛-B股票老虎国际,科笛-B行情,科笛-B股票行情,科笛-B股价,科笛-B股市,科笛-B股票价格,科笛-B股票交易,科笛-B股票购买,科笛-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}